Advances in Cell Based Assays

Explore the latest developments to extend your market dominance.

Pharmaceuticals/Drug Discovery, Medical & Health Care

Advances in Cell Based Assays 11-12 Nov 2014 London Marriott Hotel Regents Park, United Kingdom
Submit new post
Thank you for posting.
Share it:

Clinical failure in the pharmaceutical industry remains at a phenomenal 90%. Failed drugs are costly both financially and in terms of human suffering. As a result there is an urgent need in pharmaceutical and academic research for efficient and innovative processes enabling more relevant, predictive and functional cell-based assays in the drug discovery process.

Advances in Cell based Assays is the market leading event and comes at the perfect time to discuss key topics such as, phenotypic screening using cell based assays, application of 3d cultures, stem cells, label free technology as a way to innovate medicine plus much more.

Key Speakers Include:
Steve Ludbrook, Group Leader, Biological Sciences UK, RD Platform Technology and Science, GSK
Beverley Isherwood, Team Leader High Content Biology, Innovative Medicines, AstraZeneca RandD
Dr Lesley Jenkinson, Scientist 1, Medimmune
Dr Farnaz Fallah-Arani, Group Leader, Pharmacology, UCB
Neil Carragher, PhD, Principal Investigator Drug Discovery, Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh
Niclas Nilsson, Head of Section, Lead Discovery, LEO Pharma
Dr Christa Burger, Principal Scientist, Cellular Pharmacology, Merck Serono
Dr Marianne Uteng, PhD, Head of Cellular Models and HCB Laboratory, Discovery and Investigative Safety (DIS), Novartis
Anker Jon Hansen, Principal Scientist, Novo Nordisk
Daniel Nolan, Director of Research, Angiocrine Bioscience

Reasons to Attend:
Explore the latest developments in Cell Based Assays to extend your market dominance
Receive regulatory guidance with a focus on EMA and US-FDA
Join the debate and discuss how easy or not it is to use adult stem cells in therapeutic applications, in vitro and in vivo paradigm
Network and hear from over 8 leading pharmaceuticals organisations

Conference and 2 workshops: £2697+vat
Conference and 1 workshop: £2098
Conference only: £1499